Skip to main content
SpringerLink
Log in

Methylated arginine derivatives in children and adolescents with chronic kidney disease

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Asymmetric dimethylarginine (ADMA), a methylated L-arginine (Arg) derivative is associated with endothelial dysfunction, vasoconstriction, and hypertension in animals and humans. We examined the relationship between these derivatives, estimated glomerular filtration rate (eGFR), and awake (AW) and asleep (AS) blood pressure (BP) load in children and adolescents (n = 28) with stage 2–3 chronic kidney disease (CKD) and in matched intra-familial controls (n = 10). Plasma L-Arg, ADMA, and symmetric dimethylarginine (SDMA) levels were measured by high-performance liquid chromatography–tandem mass spectrometry. Subjects wore a 24-hr ambulatory BP monitor with BP load >95th percentile. ADMA, SDMA/ADMA ratio and SDMA were 38–200% higher in CKD patients while L-Arg/ADMA and L-Arg/SDMA ratios and the L-Arg level were 11–64% lower. The eGFR explained 42–60% of L-Arg/SDMA, SDMA/ADMA, and SDMA variability (n = 38). Using linear regression, SDMA and SDMA/ADMA separately explained 15–38% of AW and AS systolic (S) BP and diastolic (D) BP load variability (p < 0.001–0.022). Using multivariate stepwise regression with eGFR held constant, SDMA/ADMA was a significant independent variable for AW DBP load (p = 0.03). In conclusion, BP load and a disproportionate elevation of SDMA are seen in children and adolescents with stage 2–3 (mild–moderate) CKD. SDMA is a strong marker for reduced eGFR and serves as a moderate but significant indicator of 24-hr BP load variability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Stühlinger M, Conci E, Haubner B, Stocker E, Schwaighofer J, Cooke JP, Tsao P, Pachinger O, Metzler B (2007) Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury. Cardiovasc Res 75:417–425

    Article  Google Scholar 

  2. Busch M, Fleck C, Wolf G, Stein G (2006) Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease—possible candidates for paradoxical epidemiology. Amino Acids 30:225–232

    Article  CAS  Google Scholar 

  3. Okubo K, Hayashi K, Wakino S, Matsuda H, Kubota E, Honda M, Tokuyama H, Yamamoto T, Kajiya F, Saruta T (2005) Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension. Hypertens Res 28:181–189

    Article  CAS  Google Scholar 

  4. Landray M, Wheeler D, Lip G, Newman D, Blann A, McGlynn F, Ball S, Townend J, Baigent C (2004) Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 43:244–253

    Article  CAS  Google Scholar 

  5. Thambyrajah J, Landray M, McGlynn F, Jones H, Wheeler D, Townend J (2000) Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83:205–209

    Article  CAS  Google Scholar 

  6. McDermott J (1976) Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem J 154:179–184

    Article  CAS  Google Scholar 

  7. Bergamini S, Vandelli L, Bellei E, Rota C, Manfredini P, Tomasi A, Albertazzi A, Iannone A (2004) Relationship of asymmetric dimethylarginine to haemodialysis hypotension. Nitric Oxide 11:273–278

    Article  CAS  Google Scholar 

  8. Nijveldt R, Teerlink T, Siroen M, van Lambalgen AA, Rauwerda JA, van Leeuwen P (2003) The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 22:17–22

    Article  CAS  Google Scholar 

  9. Nijveldt R, van Leeuwen P, Van Guldener C, Stehouwer C, Rauwerda J, Teerlink T (2002) Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 17:1999–2002

    Article  CAS  Google Scholar 

  10. Carello K, Whitesall S, Lloyd M, Billecke S, D’Alecy L (2006) Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats. Am J Physiol Heart Circ Physiol 290:H209–H216

    Article  CAS  Google Scholar 

  11. Siroen M, van der Sijp J, Teerlink T, van Schaik C, Nijveldt R, van Leeuwen P (2005) The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology 41:559–565

    Article  CAS  Google Scholar 

  12. Mitsnefes M, Knilans T, Mays W, Khoury P, Daniels S (2005) Blood pressure and total peripheral resistance in children with chronic kidney disease. Pediatr Nephrol 20:803–806

    Article  Google Scholar 

  13. Goonasekera C, Rees D, Woolard P, Frend A, Shah V, Dillon M (1997) Nitric oxide synthase inhibitors and hypertension in children. J Hypertens 15:901–909

    Article  CAS  Google Scholar 

  14. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39[suppl 1]:S1–S266

    Google Scholar 

  15. Schwartz G, Brion L, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590

    Article  CAS  Google Scholar 

  16. Wang S, Vicente FB, Miller A, Brooks E, Price H, Smith F (2007) Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 45:1305–1312

    CAS  PubMed  Google Scholar 

  17. Wühl E, Witte K, Soergel M, Mehls O, Schaefer F, German Working Group on Pediatric Hypertension (2002) Distribution of 24-hour ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens 20:1995–2007

    Article  Google Scholar 

  18. MacAllister R, Rambousek M, Vallance P, Williams D, Hoffman K, Ritz E (1996) Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant 11:2449–2452

    Article  CAS  Google Scholar 

  19. Toth J, Racz A, Kaminski P, Wolin M, Bagi Z, Koller A (2007) Asymmetrical dimethylarginine inhibits shear stress-induced nitric oxide release and dilation and elicits superoxide-mediated increase in arteriolar tone. Hypertension 49:563–568

    Article  CAS  Google Scholar 

  20. Yamamizu K, Shinozaki K, Ayajiki K, Gemba M, Okamura T (2007) Oral administration of both tetrahydrobiopterin and L-arginine prevents endothelial dysfunction in rats with chronic renal failure. Cardiovasc Pharmacol 49:131–139

    Article  CAS  Google Scholar 

  21. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger R, Tripepi G, Sesti G, Zoccali C (2005) Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 46:518–523

    Article  CAS  Google Scholar 

  22. Mitsnefes M, Kimball T, Kartal J, Witt S, Glascock B, Khoury P, Daniels S (2006) Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 149:671–675

    Article  Google Scholar 

  23. Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G (2001) Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int Suppl 78:S14–S18

    Article  CAS  Google Scholar 

  24. Schmidt R, Baylis C (2000) Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 58:1261–1266

    Article  CAS  Google Scholar 

  25. Blackwell S, O’Reilly DS, Talwar D (2007) Biological variation of asymmetric dimethylarginine and related arginine metabolites and analytical performance goals for their measurement in human plasma. Eur J Clin Invest 37:364–371

    Article  CAS  Google Scholar 

  26. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, Fliser D (2006) Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-a meta-analysis. Nephrol Dial Transplant 21:2446–2451

    Article  CAS  Google Scholar 

  27. de Waard D, Dik P, Lilien M, Kok E, de Jong T (2008) Hypertension is an indication for surgery in children with ureteropelvic junction obstruction. J Urol 179:1976–1978

    Article  Google Scholar 

  28. Al Banchaabouchi M, Marescau B, Possemiers I, D’Hooge R, Levillain O, De Deyn P (2000) Ng, NG-dimethylarginine and Ng, NG-dimethylarginine in renal insufficiency. Pflugers Arch 439:524–531

    PubMed  Google Scholar 

  29. Anderstam B, Katzarski K, Bergstrom J (1997) Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients. J Am Soc Nephrol 8:1437–1442

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Kidney Diseases, Children’s Memorial Hospital and Northwestern University Feinberg Medical School, Chicago, IL, USA

    Ellen R. Brooks & Craig B. Langman

  2. Department of Pathology and Laboratory Medicine, Children’s Memorial Hospital and Northwestern University Feinberg Medical School, Chicago, IL, USA

    Sihe Wang & Frederick A. Smith

  3. Department of Pediatrics, Division of Kidney Diseases, Children’s Memorial Hospital, 2300 Children’s Plaza, Mailstop # 37, Chicago, IL, 60614, USA

    Ellen R. Brooks

  4. Department of Pediatrics, Division of Kidney Diseases, Children’s Memorial Hospital, Chicago, IL, USA

    Heather E. Price

  5. Department of Pediatrics, Division of Kidney Diseases, Children’s Memorial Hospital and Northwestern University, Chicago, IL, USA

    Abigail L. Hodges, Lara Darling & Amy Z. Yang

Authors
  1. Ellen R. Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Craig B. Langman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sihe Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heather E. Price
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Abigail L. Hodges
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lara Darling
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Amy Z. Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Frederick A. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ellen R. Brooks.

Additional information

This research was supported by the Illinois Chapter, National Kidney Foundation Grant and, in part, by Grant M01 RR-00048 from the National Center for Research Resources, National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brooks, E.R., Langman, C.B., Wang, S. et al. Methylated arginine derivatives in children and adolescents with chronic kidney disease. Pediatr Nephrol 24, 129–134 (2009). https://doi.org/10.1007/s00467-008-0972-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-008-0972-1

Keywords

Search

Navigation